Inventor · disambiguated record
Ralf Gold
Also filed as: GOLD RALF
5 granted patents·8 pending applications·5 citations·filing 1997–2020
69Inventor score
Files withBIOGEN IDEC INC3BIOGEN MA INC3FLEXOPHARM BRAIN GMBH & CO KG3FLEXOPHARM BRAIN GMBH & GO KG1GOLD RALF1
Top patents by PatentIndex Score
13 records- 0169US10695305B2Supporting immunomodulatory agentFLEXOPHARM BRAIN GMBH & CO KG·Filed 2016·Granted Jun 30, 2020·1 cites·21 claims
- 0267US10682322B2Supporting immunomodulatory agentFLEXOPHARM BRAIN GMBH & CO KG·Filed 2015·Granted Jun 16, 2020·1 cites·40 claims
- 0365US2014323570A1Neuroprotection in Demyelinating DiseasesBIOGEN IDEC INC·Filed 2014·Application pending·0 cites
- 0461US2013302410A1Neuroprotection in Demyelinating DiseasesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 0556US11865091B2Supporting immunomodulatory agentFLEXOPHARM BRAIN GMBH & CO KG·Filed 2020·Granted Jan 9, 2024·0 cites·19 claims
- 0655US2010130607A1Neuroprotection in demyelinating diseasesGOLD RALF·Filed 2008·Application pending·0 cites
- 0754US2018271821A1Neuroprotection in Demyelinating DiseasesBIOGEN MA INC·Filed 2018·Application pending·0 cites
- 0852US11471432B2Supporting immunomodulatory agentFLEXOPHARM BRAIN GMBH & GO KG·Filed 2020·Granted Oct 18, 2022·0 cites·20 claims
- 0948US2013287732A1Neuroprotection in Demyelinating DiseasesBIOGEN IDEC INC·Filed 2013·Application pending·0 cites
- 1047US2018021288A1Neuroprotection in Demyelinating DiseasesBIOGEN MA INC·Filed 2017·Application pending·0 cites
- 1146US2015267254A1Microrna profiles in the diagnosis of multiple sclerosisST JOSEF UND ST ELISABETH HOSPITAL GMBH·Filed 2013·Application pending·0 cites
- 1243US2016250172A1Neuroprotection in Demyelinating DiseasesBIOGEN MA INC·Filed 2016·Application pending·0 cites
- 1328US6319892B1Use of recombinant myelin protein for treating T-cell-mediated autoimmune diseases of the peripheral nervous systemFiled 1997·Granted Nov 20, 2001·3 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Ralf Gold files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →